Cardiovascular markers |
||||
Test Item |
Abbreviation |
Clinical application |
Specimen |
Linear range |
Cardiac Troponin I |
cTnl |
Myocardial infarction |
Whole blood, serum, plasma |
0.1~50ng/mL |
N-terminal pro b-type natriuretic peptide |
NT-proBNP |
Heart failure |
Whole blood, serum, plasma |
200~30000pg/mL |
B-type natriuretic peptide |
BNP |
Heart failure |
Whole blood, serum, plasma |
20~5000pg/mL |
Cardiac Troponin I/Myoglobin/Creatine Kinase Isoenzyme |
cTnl/MYO/CK-MB |
Myocardial infarction, myocardial damage, differentiation of cardiogenic dyspnea and pulmonary dyspnea |
Whole blood, serum, plasma |
cTnI:0.2~50ng/mL; Myo:20~500ng/mL; CK-MB:2~100ng/mL |
Heart-type fatty acid binding protein |
H-FABP |
Early markers of acute myocardial infarction, myocardial damage |
Whole blood, serum, plasma |
1~120ng/mL |
D-dimer |
D-D |
Exclusion diagnosis of deep vein thrombosis and pulmonary embolism, evaluation of thrombolytic effect |
Whole blood, plasma |
0.2~10.0µg/mL |
Lipoprotein-associated phospholipase A2 |
Lp-PLA2 |
Atherosclerosis, cardiovascular and cerebrovascular embolization |
Whole blood, serum, plasma |
10~1000ng/mL |
Soluble growth stimulation expressed gene 2 protein |
ST2 |
Heart failure marker |
Whole blood, serum, plasma |
2~200ng/mL |
Human S100-β protein |
S100-β |
Early diagnosis and detection of acute brain injury |
Whole blood, serum, plasma |
0.1~10ng/mL |
Online Inquiry
If you are interested in our products, please leave your email, we will contact you as soon as possible, thank you!